Status: Not yet recruiting
A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder
This study will evaluate the safety and exploratory efficacy of AFA-281 in patients with Alcohol use disorder on cravings, subjective response to alcohol, pain thresholds, anxiety, depression, and sleep.
Participants needed: 36
Trial details
Phase: Phase 2Age: 21-65Biological sex: AllType: InterventionalSponsor: Afasci IncUpdated: Nov 29, 2024Locations: 1
Eligibility criteria
Age between 21 and 65 [+4]
Current treatment for alcohol use or a history of treatment in the 30 days befor... [+24]